Insider Transactions in Q2 2023 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2023
|
Michael Craig Diem Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
151,058
+35.51%
|
-
|
|
May 15
2023
|
Douglas Carr SVP Finance & Operations |
BUY
Grant, award, or other acquisition
|
Direct |
120,846
+27.33%
|
-
|
|
Apr 03
2023
|
Luis Borges Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,452
+2.82%
|
$7,452
$1.03 P/Share
|